RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy
NCT03458234 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2024-05-20
Summary
This study offers focal therapy for prostate cancer by using an intra-urethral radiotransponder temporarily placed during radiotherapy. The study aims to improve the risk-benefit ratio of therapy for early prostate cancer and potentially lessen symptom burden over time.
Conditions
Interventions
- DEVICE
-
16 French Foley Catheter
A Foley catheter is a medical apparatus that creates a passageway for the drainage and collection of urine. This type of catheter is made of a pliable material that indwells into an individual's bladder by way of the urethra. Featuring two separate channels down the tube, Foley catheters allow absolute stability and safe extraction. One channel of the catheter, by method of a balloon, is stabilized in a bladder; the other channel allows for the passage and collection of urine, by means of a leg bag or bedside drainage bag. Foley catheters are usually constructed out of either silicone or latex.
Sponsors & Collaborators
-
Varian Medical Systems
collaborator INDUSTRY -
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Andrew M McDonald, MD · University of Alabama at Birmingham
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-28
- Primary Completion
- 2023-04-20
- Completion
- 2023-06-22
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00124917 ·Status: TERMINATED ·Phase: PHASE1
-
Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer
NCT01163448 ·Status: WITHDRAWN ·Phase: PHASE1
-
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer
NCT00039624 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer
NCT00243321 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of SBRT and CDX-1127 in Prostate Cancer
NCT02284971 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
NCT01540994 ·Status: COMPLETED ·Phase: NA
-
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
NCT03253744 ·Status: COMPLETED ·Phase: PHASE1
-
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT02597894 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
NCT02163317 ·Status: COMPLETED ·Phase: NA
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00714753 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study on Focal Prostate Radio-Frequency Ablation
NCT01423006 ·Status: COMPLETED ·Phase: NA
-
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer
NCT05010759 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
NCT02280356 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
NCT00499421 ·Status: COMPLETED
-
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence
NCT04645810 ·Status: WITHDRAWN ·Phase: NA
-
MRI Guided Prostate Cancer Focal Laser Ablation
NCT03634579 ·Status: TERMINATED ·Phase: NA
-
Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer
NCT02290366 ·Status: WITHDRAWN ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT03541850 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
NCT01859689 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase I Study MR-guided SBRT to PCa
NCT03935308 ·Status: WITHDRAWN ·Phase: NA
-
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
NCT06369246 ·Status: RECRUITING ·Phase: PHASE1
-
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions
NCT03998657 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
NCT03417336 ·Status: RECRUITING ·Phase: NA
-
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
NCT05616650 ·Status: RECRUITING ·Phase: PHASE2